Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» brain cancer
brain cancer
Scorpion Venom Could Improve Immuno-Oncology Therapies in Brain Cancer
BioSpace
Thu, 03/5/20 - 10:49 am
brain cancer
drug development
CAR-T
City of Hope
scorpion venom
A Blood Test for Brain Cancer with a Dash of AI Added
Medical Devices and Diagnostics Industry
Wed, 10/9/19 - 10:58 pm
diagnostics
brain cancer
ClinSpec Diagnostics
artificial intelligence
Tocagen's brain cancer treatment fails late-stage study, shares crash
Reuters
Thu, 09/12/19 - 10:53 pm
Tocagen
clinical trials
brain cancer
Toca 511
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Endpoints
Thu, 09/5/19 - 10:13 am
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Pharmaforum
Fri, 07/12/19 - 12:05 pm
Karyopharm
Xpovio
brain cancer
Selinexor
clinical trials
glioblastoma
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Thu, 06/20/19 - 09:50 am
Bayer
brain cancer
clinical trials
GBM
regorafenib
No news is bad news for Tocagen
BioPharma Dive
Wed, 05/22/19 - 08:31 pm
Tocagen
Toca 511
Toca FC
brain cancer
clinical trials
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Fri, 05/17/19 - 10:05 am
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
Two papers open door to T cell brain entry for glioblastoma therapy
BioCentury
Thu, 09/6/18 - 11:44 am
T-cells
glioblastoma
brain cancer
Nature
Freshly IPO’d Tocagen tweaks brain cancer gene therapy test
Fierce Biotech
Sat, 10/28/17 - 11:14 pm
Tocagen
brain cancer
gene therapy
Toca 511
Toca FC
Novogen irons out Phase 2 plans for brain cancer candidate
BioPharma Dive
Wed, 08/23/17 - 11:12 am
Novagen
clinical trials
GDC-0084
glioblastoma multiforme
brain cancer
Bristol-Myers’ checkpoint star Opdivo fails a PhIII study for glioblastoma
Endpoints
Tue, 04/4/17 - 07:35 pm
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
FDA Allows Ziopharm Brain Cancer Drug Trial
Investopedia
Mon, 03/27/17 - 10:26 pm
FDA
Ziopharm
brain cancer
clinical trials
Ad-RTS-hIL-12
glioblastoma
Tracon Tanks on Brain Cancer Drug Failure
Investopedia
Mon, 02/13/17 - 10:11 am
TRACON Pharmaceuticals
glioblastoma multiforme
brain cancer
TRC105
Northwest Bio Spikes on Lifting of Clinical Hold
Investopedia
Tue, 02/7/17 - 06:16 pm
Northwest Biotherapeutics
DCVax-L
glioblastoma multiforme
brain cancer
Fortress Bio soars after reporting breakthrough with CAR-T cancer approach
Marketwatch
Thu, 12/29/16 - 10:22 am
Fortress Biotech
CAR-T
MB-101
brain cancer
CAR-T therapy makes early inroads in treating brain cancer
Stat
Wed, 12/28/16 - 07:35 pm
CAR-T
glioblastoma
brain cancer
AbbVie Presents Encouraging Phase 1 Data for Investigational Medicine ABT-414 as Monotherapy in Patients with an Aggressive Brain Cancer at the 2016 American Society of Clinical Oncology Annual Meeting
Yahoo
Sun, 06/5/16 - 12:03 pm
AbbVie
glioblastoma
brain cancer
ASCO 2016
ABT-414
A Look at Four Brain Cancer Companies for 2016
Yahoo
Mon, 01/4/16 - 12:24 pm
brain cancer
Del Mar
ImmunoCellular Therapeutics
Vascular Biogenics
Burzynski Research Institute
Merck's Keytruda gets presidential lift as Jimmy Carter announces he's cancer-free
BioPharma Dive
Mon, 12/7/15 - 12:09 pm
Merck
Keytruda
brain cancer
cancer immunotherapy
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »